MatthewKaagMD

PubMed

• Concurrent durvalumab and radiation therapy (DUART) followed by adjuvant durvalumab in patients with localized urothelial cancer of bladder: results from phase II stud...
  Monika Joshi, Leonard Tuanquin, Junjia Zhu, Vonn Walter, Todd Schell, Matthew Kaag, Deepak Kilari, Jiangang Liao, Sheldon L Holder, Hamid Emamekhoo, Alexander Sankin, ...> ;Journal for Immunotherapy of Cancer. 2023 Feb 1
• Significant Bleeding Complications Following Transrectal Prostate Needle Biopsy: Incidence, Predictors, and Management.
  Jay Fuletra, Chris Rjepaj, Joseph Y Clark, John J Knoedler, Susan M MacDonald, Matthew G Kaag, Suzanne B Merrill, Jay D Raman> ;Urology Practice. 2023 Jan 1
• Author Correction: FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation.
  Joshua I Warrick, Wenhuo Hu, Hironobu Yamashita, Vonn Walter, Lauren Shuman, Jenna M Craig, Lan L Gellert, Mauro A A Castro, A Gordon Robertson, Fengshen Kuo, Irina Os...> ;Nature Communications. 2022 Dec 23
• FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation.
  Joshua I Warrick, Wenhuo Hu, Hironobu Yamashita, Vonn Walter, Lauren Shuman, Jenna M Craig, Lan L Gellert, Mauro A A Castro, A Gordon Robertson, Fengshen Kuo, Irina Os...> ;Nature Communications. 2022 Nov 2
• Impact of an inpatient advanced practice provider on hospital length of stay after major urologic oncology procedures.
  Benjamin P Hull, Michael D Humphrey, Kathleen K Lehman, Matthew G Kaag, Suzanne B Merrill, Jay D Raman> ;Urologic Oncology. 2022 Sep 1
• Patient Perceptions Regarding Routine Oncologic Follow-Up for Urologic Malignancies.
  Sarah A Strausser, R Grant Owens, Tyler Vu, Ellius Kwok, Eric W Schaefer, Suzanne Boltz, Alireza Aminsharifi, Matthew Kaag, Jay D Raman, Suzanne B Merrill> ;Clinical Genitourinary Cancer. 2022 Jun 1
• Diagnostic Imaging in Low-Risk Prostate Cancer: More Harm Than Good?
  Justin Loloi, Joshua M Eccles, Grant Owens, Erik Lehman, Matthew G Kaag, Jay D Raman, Suzanne B Merrill> ;Urology Practice. 2022 Mar 1
• 7 citations
  Topical antiseptic at time of transrectal ultrasound prostate biopsy is associated with fewer severe clinical infections and improves antibiotic stewardship
  Shayann Ramedani, Joseph Y. Clark, John J. Knoedler, Susan MacDonald, Matthew Kaag, Suzanne B. Merrill, Jay D. Raman> ;Prostate International. 2021 May 27
• Is pelvic MRI imaging sufficient cross-sectional imaging for staging intermediate and high-risk prostate cancer?
  R. Grant Owens, Justin Loloi, Erik Lehman, Matthew Kaag, Jay D. Raman, Suzanne B. Merrill> ;Urologic Oncology. 2021 Feb 17
• 2 citations
  Histologic Heterogeneity of Extirpated Renal Cell Carcinoma Specimens: Implications for Renal Mass Biopsy
  Lauren M Nahouraii, Jordan L Allen, Suzanne B. Merrill, Erik Lehman, Matthew Kaag, Jay D. Raman> ;Journal of Kidney Cancer and VHL. 2020 Aug 25
• Can preoperative imaging characteristics predict pT3 bladder cancer following cystectomy
  Jay Fuletra, Andrew Watts, Matthew Kaag, Erik Lehman, Jay D. Raman, Suzanne B. Merrill> ;World Journal of Urology. 2021 Jun 1
• 4 citations
  Development and evaluation of a bladder Cancer specific survivorship care plan by patients and clinical care providers: a multi-methods approach
  Cheryl T. Lee, Nihal Mohamed, Sailaja Pisipati, Qainat N. Shah, Piyush K. Agarwal, Tracy M. Downs, Michael J. Droller, Scott M. Gilbert, Heather Honoré Goltz, Simon Ha...> ;BMC Health Services Research. 2020 Jul 24
• 1 citations
  Hemostatic agent use during partial nephrectomy: trends, outcomes, and associated costs
  Adri Durant, Erik Lehman, Haley Robyak, Suzanne B. Merrill, Matthew Kaag, Jay D. Raman> ;International Urology and Nephrology. 2020 Jun 15
• 1 citations
  Perioperative chemotherapy in the management of high risk upper tract urothelial cancers.
  Matthew Kaag> ;Translational Andrology and Urology. 2020 Apr 26
• 31 citations
  Evaluation of PD-L1 and other immune markers in bladder urothelial carcinoma stratified by histologic variants and molecular subtypes.
  Huili Li, Qingzhao Zhang, Lauren Shuman, Matthew Kaag, Jay D. Raman, Suzanne B. Merrill, David J. DeGraff, Joshua I. Warrick, Guoli Chen> ;Scientific Reports. 2020 Jan 29
• 14 citations
  Repression of transcription factor AP-2 alpha by PPARγ reveals a novel transcriptional circuit in basal-squamous bladder cancer.
  Hironobu Yamashita, Yuka Imamura Kawasawa, Lauren Shuman, Zongyu Zheng, Truc Tran, Vonn Walter, Joshua I. Warrick, Guoli Chen, Hikmat Al-Ahmadie, Matthew Kaag, Pak Kin...> ;Oncogenesis. 2019 Nov 26
• Editorial Comment.
  Matthew G Kaag> ;The Journal of Urology. 2019 Jul 1
• 13 citations
  Characterization of Histone Deacetylase Expression Within In Vitro and In Vivo Bladder Cancer Model Systems
  Jenna M. Buckwalter, Wilson Chan, Lauren Shuman, Thomas Wildermuth, Justine Ellis-Mohl, Vonn Walter, Joshua I. Warrick, Xue-Ru Wu, Matthew Kaag, Jay D. Raman, David J....> ;International Journal of Molecular Sciences. 2019 May 27
• 5 citations
  Capturing Renal Cell Carcinoma Recurrences When Asymptomatic Improves Patient Survival.
  Suzanne B. Merrill, Brian S. Sohl, Ashiya Hamirani, Erik Lehman, Kathleen Lehman, Matthew Kaag, Jay D. Raman> ;Clinical Genitourinary Cancer. 2019 Apr 1
• 38 citations
  Single-dose radiotherapy disables tumor cell homologous recombination via ischemia/reperfusion injury
  Sahra Bodo, Cecile G. Campagne, Tin Htwe Thin, Daniel S. Higginson, H. Alberto Vargas, Guoqiang Hua, John D. Fuller, Ellen Ackerstaff, James A. Russell, Zhigang Zhang,...> ;The Journal of Clinical Investigation. 2019 Feb 1
• 6 citations
  Mitotic activity in noninvasive papillary urothelial carcinoma: its value in predicting tumor recurrence and comparison with the contemporary 2-tier grading system.
  Michael Zaleski, Augustyna Gogoj, Vonn Walter, Jay D. Raman, Matthew Kaag, Suzanne B. Merrill, Joseph J. Drabick, Monika Joshi, Sheldon L. Holder, David J. DeGraff, Jo...> ;Human Pathology. 2019 Feb 1
• 1 citations
  Sarcopenia is a reliable predictor of outcomes following radical cystectomy for bladder cancer
  Matthew Kaag, Jay D. Raman> ;Translational Andrology and Urology. 2018 Dec 1
• 126 citations
  Intratumoral Heterogeneity of Bladder Cancer by Molecular Subtypes and Histologic Variants
  Joshua I. Warrick, Gottfrid Sjödahl, Matthew Kaag, Jay D. Raman, Suzanne B. Merrill, Lauren Shuman, Guoli Chen, Vonn Walter, David J. DeGraff> ;European Urology. 2019 Jan 1
• 10 citations
  Impact of United States Preventive Services Task Force recommendations on prostate biopsy characteristics and disease presentation at a tertiary-care medical center.
  Brian M. Blair, Haley Robyak, Joseph Y. Clark, Matthew Kaag, Erik Lehman, Jay D. Raman> ;Prostate International. 2018 Mar 9
• 3 citations
  Topical rectal antiseptic at time of prostate biopsy: how a resident patient safety project has evolved into institutional practice
  Rosa Park, Justin Gyorfi, Kalyan K. Dewan, Girish S. Kirimanjeswara, Joseph Y. Clark, Matthew Kaag, Kathleen Lehman, Jay D. Raman> ;International Urology and Nephrology. 2018 Jul 17
• Join now to see all

Journal Articles

• Original Contribution Mitotic Activity in Non-Invasive Papillary Urothelial Carcinoma: Its Value in Predicting Tumor Recurrence, and Comparison to the Contemporary Two...  
  Augustyna Gogoj, Suzanne B Merrill, Monika Joshi, Sheldon Holder, Joshua I Warrick, Matthew Kaag, Jay D Raman, Joseph Drabick, ScienceDirect
• Predicted Versus Observed 30-Day Perioperative Outcomes Using the ACS NSQIP Surgical Risk Calculator in Patients Undergoing Partial Nephrectomy for Renal Cell Carcinoma  
  Brian M Blair, Jay D Raman, Matthew G Kaag, International Urology and Nephrology